Introduction {#s1}
============

Evolution of multicellular life on Earth has occurred in the presence of diverse microorganisms (e.g. bacteria, fungi, viruses, and protozoa). In each animal life cycle, all exposed body surfaces are colonized by microbial communities, collectively referred to as the microbiota. Although these microbes can be found on distinct body sites, the most densely populated host compartment is the intestinal tract ([@B1]). The intestine of vertebrates is comprised of a single epithelial layer of intestinal epithelial cells (IECs) that forms a tube with a single continuous lumen allowing for the passage and absorption of dietary nutrients. The interactions in that habitat between animal hosts and their microbiota significantly shape animal biology over evolutionary and individual lifecycle time scales ([@B2]).

The detection of microbiota by host cells, including IECs, is critical for the maintenance of homeostasis and prevention of infection by pathogenic microbes ([@B3], [@B4]). The balance between host tolerance and inflammatory responses to commensal microorganisms is achieved through an intricate molecular dialog between microorganisms and their hosts. The innate immune system is an ancient host defense program wherein humoral and cellular components function synergistically to protect animals from infection by microorganisms. Innate immune responses occur over relatively short temporal timescales and have historically been considered to be generalizable and non-specific ([@B5]). However, there is emerging evidence challenging this dogma, whereby innate immune cells display genomic alterations that augment responses to repeated inflammatory stimuli suggestive of innate immune memory ([@B6]--[@B8]). Reactive oxygen species (ROS) in combination with secreted proteins such as anti-microbial proteins and complement factors target and kill microbes. Cellular components include myeloid cells, such as macrophages (matured from monocytes) and neutrophils, that function as professional phagocytes that engulf microorganisms and necrotic cells. While it is well-established that the microbiota promote innate immune responses in homeostasis and following injury, identification of underlying mechanisms remains a major research priority.

Microorganisms possess highly conserved molecular signatures, referred to as microbe associated molecular patterns (MAMPs). MAMPs are recognized by host cells as foreign stimuli and include the microbial surface components LPS, peptidoglycan, and flagella. Host cells detect extracellular and intracellular MAMPs through highly-conserved pattern recognition receptors (PRRs) located in both the plasma membrane and cytosol. The most thoroughly characterized PRRs include Toll like receptors (TLRs), nucleotide binding oligomerization domain (NOD) like receptors (NLRs), and RIG-I like receptors (RLRs). Host PRRs are ancient microbial sensors that have co-evolved with symbiotic commensal microbiota and pathogens. Activation of host PRRs leads to conserved signaling cascades mediated by adaptor proteins, kinases, and transcription factors, ultimately resulting in increased expression of cytokines, chemokines, and anti-microbial factors ([@B3]).

Despite being spatially compartmentalized within anatomical compartments including the intestine, oral cavity, skin, and urogenital tract, the microbiota impacts systemic host innate immune processes ([@B9]--[@B11]). Correlative studies performed in humans provide insights into the relationship between microbiota composition and specific states of disease or environmental exposure. However, mechanistic interrogation of host-microbe interactions is difficult to achieve with human studies alone, and thus animal models are essential tools for experimental manipulations. Application of gnotobiotic technologies (the ability to experimentally manipulate host-associated microbiotas) to commonly used model organisms has facilitated dissection of the influence of commensal microbes on host physiologies. To elucidate the impacts of the microbiota on host processes, animals can be derived germ-free (GF) through a variety of techniques, resulting in a sterile (or axenic) organisms devoid of microbes ([@B12]). Specific microbial strains or complex microbial consortia of interest can then be introduced to interrogate the effects of microbiota colonization on host physiology in a controlled system. Gnotobiotic mice have been instrumental in revealing the influence of microbiota on numerous aspects of host biology from development, metabolism, behavior and immunity ([@B13]). In addition to murine models, methods have been developed to rear other vertebrate and non-vertebrate animal models under gnotobiotic conditions. Fruit flies, worms, and fishes can be derived GF and subsequently colonized with a variety of microbial communities of varying composition and complexity ([@B14]). Here we review insights gained into microbiota control of vertebrate innate immunity using the zebrafish model.

Evaluating Host-Microbe Interactions in Gnotobiotic Zebrafish
-------------------------------------------------------------

Zebrafish (*Danio rerio*) are a genetically tractable vertebrate model organism native to fresh water ecosystems of India, Burma, Bangladesh, and Nepal ([@B15], [@B16]). The zebrafish life cycle begins with external fertilization and embryonic development within the protective and axenic confines of the chorion, a protective membrane that is typically impermeable to microbial cells. Colonization of the developing zebrafish is thought to initially occur when larvae hatch from their chorions at approximately 3 days post-fertilization (dpf), coincident with the lumen formation of the developing intestinal tract. Zebrafish share many key anatomical and physiological features with mammalian digestive systems, including an intestinal tract comprised of differentiated absorptive and secretory epithelial cells which is capable of both absorbing diverse dietary nutrients and forming a protective barrier against lumenal factors including microbes ([@B17], [@B18]). 16S rRNA gene sequencing demonstrated that the zebrafish gut-associated microbiota is dominated by Proteobacteria at all developmental timepoints, although there is an expansion of Firmicutes and Fusobacteria at later adult stages ([@B18]--[@B21]). Bacterial taxa that colonize mammalian guts, such as Bacteroidetes and lactic acid bacteria (e.g., *Lactococcus lactis, Lactobacillus fermentum*, and *Weissella confusa*), have also been detected within the zebrafish intestine ([@B18]). However, reciprocal gut microbiota transplants between zebrafish and mice revealed the zebrafish intestine selects for a distinct microbial community as compared to mouse ([@B18], [@B22]). Like mammalian intestinal microbiotas, the composition of zebrafish intestinal microbial communities is responsive to dietary perturbations and varies substantially across aquaculture facilities ([@B21], [@B23]--[@B25]).

Methods to derive zebrafish embryos germ free (GF) and their subsequent rearing under gnotobiotic conditions are well-established ([@B26], [@B27]). While gnotobiotic husbandry of murine model organisms is technically challenging and expensive, zebrafish can be maintained germ-free or colonized with defined bacterial strains or communities (conventionalized---CV) with ease and at relatively low cost ([Table 1](#T1){ref-type="table"}). Briefly, zebrafish embryos residing within the axenic environment of a protective chorion are passaged through a series of antibiotic, iodine, and bleach baths that sterilize the surface of the chorion. Subsequently, those derived zebrafish are housed in sterile media and provided sterilized diets when warranted. Microbial consortia, strains, or their products can be added to the housing media to test their impact on host biology or their ecology in association with the host. Inoculation of GF zebrafish larvae with complex bacterial communities or defined strains demonstrated that even some mammalian commensal taxa, such as *Escherichia, Enterococcus, Bacillus, Roseburia*, and *Prevotella*, can colonize zebrafish larvae ([@B22], [@B42]), thus enabling the use of "humanized" zebrafish to for medium-throughput investigation of host-microbiota interactions. Furthermore, probiotic bacterial strains including several species of *Lactobacilli*, colonize zebrafish and can influence host immune responses and outcomes to bacterial infection ([@B37]--[@B39], [@B43], [@B44]). Over the last 15 years, these foundational insights and methods have allowed the zebrafish to become established as a valuable new vertebrate model for investigating host-microbiota interactions.

###### 

Microbial specific effects on zebrafish innate immunity.

  **Microbial taxa or product**                         **Phenotype**                                                                                                                                                                                                                 **Tissue**                                       **References**
  ----------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------ --------------------------
  Complex microbiota (CV)                               Increased neutrophil recruitment vs. GF                                                                                                                                                                                       Gut                                              ([@B28], [@B29])
                                                        Increased systemic abundance of neutrophils                                                                                                                                                                                   Whole 6 dpf larvae                               ([@B28], [@B29])
                                                        Increased neutrophil velocity                                                                                                                                                                                                 Gut, CHT, fin                                    ([@B28])
                                                        Increased neutrophil recruitment to tail wound;                                                                                                                                                                               Caudal fin                                       ([@B28], [@B30], [@B31])
                                                        Increased NF-κB signaling                                                                                                                                                                                                     Gut, swim bladder                                ([@B32])
                                                        Increased pro-inflammatory mRNAs                                                                                                                                                                                              Dissected digestive tissue                       ([@B22], [@B32])
                                                        Increased *intestinal alkaline phosphatase* expression and LPS detoxification                                                                                                                                                 Dissected digestive tissue                       ([@B33])
  *Shewanella* sp. ZOR0012                              Gut CFU negatively correlated to neutrophil number                                                                                                                                                                            Gut                                              ([@B29])
  *Shewanella* sp. ZWU0012 (previous name T1E1C05)      Gut CFU negatively correlated to neutrophil number                                                                                                                                                                            Dissected digestive tissue                       ([@B22])
  *Aeromonas* sp. ZWU0008 (previous name T1E1A06)       Increased pro-inflammatory mRNAs                                                                                                                                                                                              Dissected digestive tissue                       ([@B22])
  *Aeromonas* sp. ZOR0001                               Increased neutrophil recruitment vs. GF                                                                                                                                                                                       Gut                                              ([@B29])
  *Vibrio* sp. ZWU0020                                  Increased neutrophil recruitment vs. GF                                                                                                                                                                                       Gut                                              ([@B29])
  *Acinetobacter* sp. ZOR0008                           Decreased neutrophil number vs. CV                                                                                                                                                                                            Gut                                              ([@B29])
  *Plesiomonas* sp. ZWU0015 (previous name T1N1D03)     Increased pro-inflammatory mRNAs                                                                                                                                                                                              Dissected digestive tissue                       ([@B22])
  *Plesiomonas* sp. ZOR0011                             No difference in neutrophil recruitment vs. GF                                                                                                                                                                                Gut                                              ([@B29])
  *Enterobacter* sp. ZOR0014                            No difference in neutrophil recruitment vs. GF                                                                                                                                                                                Gut                                              ([@B29])
  *Delftia* sp. ZNC0008                                 Decreased neutrophil number vs. CV                                                                                                                                                                                            Gut                                              ([@B29])
  *Variovorax* sp. ZNC0006                              Decreased neutrophil number vs. CV                                                                                                                                                                                            Gut                                              ([@B29])
  AimA (secreted from *Aeromonas* sp.)                  Dampens neutrophil recruitment                                                                                                                                                                                                Gut                                              ([@B34])
  *Exiguobacterium acetylicum* ZWU0009                  Increased expression of genes involved in (1) cell matrix adhesion and (2) response to bacterium                                                                                                                              Whole animal                                     ([@B35])
  *Chryseobacterium sp*. ZOR0023                        Increased expression of genes involved in (1) negative regulation of cell proliferation, (2) cell-cell adhesion, (3) regulation of MAPK activity, (4) apoptotic process, (5) activation of endopeptidase, (6) transcription   Whole animal                                     ([@B35])
  *Aeromonas hydrophila* ATCC35654                      Increased expression of pro-inflammatory mRNAs                                                                                                                                                                                Dissected digestive tissue                       ([@B18], [@B22])
  *Pseudomonas aeruginosa* PAO1                         Increased expression of pro-inflammatory mRNAs (*saa* and *mpx*)                                                                                                                                                              Dissected digestive tissue                       ([@B22])
  *P. aeruginosa* PAK                                   Increased NF-κB activation                                                                                                                                                                                                    Gut, liver, swim bladder, muscle, whole animal   ([@B32], [@B36])
  *P. aeruginosa* ΔfliC PAK                             No significant NF-κb activation; increased NF-κb activation                                                                                                                                                                   Gut, whole animal; swim bladder, muscle          ([@B32], [@B36])
  *P. aeruginosa* ΔmotACBD PAK                          No significant NF-κb activation; increased NF-κb activation                                                                                                                                                                   Gut, whole animal; liver and muscle              ([@B32], [@B36])
  *P. aeruginosa* LPS                                   Increased expression of pro-inflammatory mRNAs (*saa* and *mpx*)                                                                                                                                                              Dissected digestive tissue                       ([@B22])
  *Escherichia coli* MG1655                             Increased expression of pro-inflammatory mRNAs (*saa* and *mpx*)                                                                                                                                                              Dissected digestive tissue                       ([@B22])
  *Staphylococcus* sp. MWU0002 (previous name M2EA04)   No significant increase in pro-inflammatory mRNAs vs. GF (*saa* and *mpx*)                                                                                                                                                    Dissected digestive tissue                       ([@B22])
  *Enterococcus* sp. MWU0002 (previous name M2E1F06)    No significant increase in pro-inflammatory mRNAs vs. GF (*saa* and *mpx*)                                                                                                                                                    Dissected digestive tissue                       ([@B22])
  *Citrobacter* sp. ZWU0013 (previous name T1E1C07)     Increased expression of pro-inflammatory mRNAs (*saa* and *mpx*)                                                                                                                                                              Dissected digestive tissue                       ([@B22])
  *Lactobacillus casei* BL23                            Protective against *Aeromonas veronii* infection, increased expression of *tnfa, il1b, il10*, and *saa*                                                                                                                       Whole animal                                     ([@B37])
  *Lactobacillus plantarum* ST-III                      Protects against toxic effect of triclosan by mediating microbiota composition                                                                                                                                                Gut                                              ([@B38])
  *Lactobacillus rhamnosus* IMC 501                     Increased expression of pro-inflammatory mRNAs *il1b* and *tnfa*; modulates commensal microbiota and host gene expression of lipid metabolism genes                                                                           Dissected adult intestine; larval gut            ([@B39], [@B40])
  *Lactobacillus casei* BL23 EPS                        Protects against high fat diet induced hepatic steatosis                                                                                                                                                                      Liver                                            ([@B41])
  *Lactobacillus rhamnosus* GG EPS                      Protects against high fat diet induced hepatic steatosis                                                                                                                                                                      Liver                                            ([@B41])

Zebrafish as a Model to Study Innate Immunity
---------------------------------------------

In parallel to its advancement as a model for host-microbiota interactions, the zebrafish has also emerged as a powerful vertebrate model for the study of innate immunology. The zebrafish offers several advantages for such studies, including a fully sequenced genome and a complement of genetic tools which facilitate transgenesis and mutagenesis. Zebrafish possess hematopoietic lineages that are highly-conserved with those of mammals which function analogously to counteract inflammatory stimuli and maintain host heath ([@B45]). The zebrafish genome encodes a number of TLRs and NLRs that are expressed in diverse cell and tissue types where they respond to inflammatory stimuli ([@B46]). Surveillance of the extracellular and intracellular environments by these host PRRs functions to activate immune pathways and promoting immunological tolerance or inflammatory responses following microbial stimulation or tissue injury.

Prior to 4 weeks of age, zebrafish do not possess a fully functional adaptive immune system ([@B47]). The innate immune system plays a pivotal role during this period, functioning as the sole defense against microbial invasion in zebrafish larvae. This affords a unique opportunity to study the innate immune system in isolation, which cannot be easily achieved in mammalian models. Early in development (\~22--33 h post fertilization), primitive immune cells are derived from the yolk sac and the intermediate cell mass ICM (analogous to the mammalian yolk sac) ([@B48]). Definitive hematopoiesis begins approximately at 1 dpf, giving rise to multiple lineages of immune cells including neutrophils and macrophages. HSCs (hematopoietic stem cells; *runx-, c-myb-*, and/or *cd41-*positive) travel from the aorta-gonad-mesonephros (AGM) to populate the caudal hematopoietic tissue (CHT), kidney, and thymus ([@B49]). Myeloid cells including monocytes, macrophages, neutrophils, mast cells, dendritic cells and eosinophils have been described in zebrafish ([@B50]--[@B54]) ([Table 2](#T2){ref-type="table"}). Cytological, transcriptomic, and functional analyses of zebrafish myeloid cells indicate that these populations function analogously to mammalian counterparts ([@B45]). Importantly, the optical transparency of zebrafish larvae offers un-paralleled opportunities to use transgenic reporters for assessing spatiotemporal leukocyte responses to a variety of inflammatory stimuli in ways that are not feasible in mammalian models.

###### 

Myeloid lineages described in zebrafish.

  **Innate immune cell type**   **Promoter/BAC transgenic element**   **Antibody**        **Histochemical stain**                                                                           **References**
  ----------------------------- ------------------------------------- ------------------- ------------------------------------------------------------------------------------------------- --------------------------
  Neutrophil                    *lyz, mpx*                            Mpx; L-plastin      Sudan black; myeloperoxidase; periodic acid--Schiff, toluidine blue, Wright-Giemsa (WG)           ([@B55], [@B56])
  Macrophage                    *mpeg1, mfap4, irg1*                  L-plastin           Neutral red; Wright-Giemsa (WG)                                                                   ([@B57], [@B58])
  Dendritic cell                *mpx*                                 N/A                 Wright-Giemsa (WG); peanut agglutinin (PGA)                                                       ([@B53])
  Mast cell                     *cpa5*                                Anti-human FcεRIγ   Hematoxylin and eosin, periodic acid--Schiff, toluidine blue, KIT, tryptase, Wright-Giemsa (WG)   ([@B52], [@B59], [@B60])
  Eosinophil                    *gata2* (EGFP-hi)                     N/A                 Periodic acid-Schiff, myeloperoxidase, toluidine blue, Wright Giemsa                              ([@B54])
  HSC                           *cd41; runx1; gata2b*                 N/A                 N/A                                                                                               ([@B61])

As described in the following sections, studies in gnotobiotic zebrafish have revealed highly-conserved innate immune responses to microbiota colonization. Although not detailed in this review, the commensal microbiota further elicits alterations in zebrafish development, behavior, and metabolism analogous to mammalian counterparts, underscoring the utility of the zebrafish as a tractable model to study host-microbe interactions ([@B18], [@B19], [@B22], [@B33], [@B62]--[@B64]). Additionally, although not discussed here, zebrafish models of infectious disease have also provided critical insights into the mechanisms of host-pathogen interactions. In particular, numerous studies using the natural fish pathogen *Mycobacterium marinum* (which is closely related to the *Mycobacterium tuberculosis* complex), have identified both host and bacterial mechanisms that underlie disease severity which are conserved with human tuberculosis ([@B65], [@B66]).

Microbiota Influences Steady State Innate Immunity in Zebrafish
---------------------------------------------------------------

Colonization of zebrafish larvae with a complex microbiota stimulates innate immune responses that have also been observed in mammals, underscoring the importance of these responses over evolutionary timescales ([@B18], [@B19], [@B22]) ([Figure 1](#F1){ref-type="fig"}, [Table 3](#T3){ref-type="table"}). Innate immune activation by commensal microorganisms is achieved, in part, through host gene expression programs. Studies in mice have reported microbiota-dependent host transcriptional responses in intestinal epithelia, including marked induction of genes encoding cytokines, chemokines, anti-microbial peptides, and other inflammatory mediators ([@B17], [@B62], [@B67], [@B69], [@B95], [@B96]). Similarly, facile gnotobiotic manipulations in zebrafish larvae have allowed for investigation into the impact of specific bacterial strains on host innate immune signaling more quickly and with greater scalability than comparable experiments in murine models. Application of mono- and poly-association studies in gnotobiotic zebrafish larvae have illustrated microbe-specific impacts on host innate immunity ([Table 1](#T1){ref-type="table"}) ([@B22], [@B29], [@B35]). Our transcriptomic analyses of digestive tracts of germ-free and conventionalized zebrafish larvae revealed many genes are regulated by microbiota. Moreover, many microbiota-responsive zebrafish genes have mouse homologs that are also similarly transcriptionally responsive to microbiota colonization in the intestine, indicating that host responses to the microbiota are deeply conserved during vertebrate evolution ([@B18]). Notably, innate immune genes involved in anti-microbial peroxide production and signaling to leukocytes, *myeloperoxidase* (*mpx*) and *serum amyloid a* (*saa*), exhibited dynamic and variable transcriptional induction in zebrafish digestive tracts following colonization with complex microbiota and individual bacterial taxa. Some bacteria including *Pseudomonas aeruginosa, Aeromonas hydrophila*, and *Escherichia coli* strains potently induced *mpx* and *saa* transcripts, whereas other strains including *Shewanella* sp. and *Staphylococcus* sp. failed to induce transcription of these same genes. Further, complex communities of microbes isolated from zebrafish digestive tracts more potently stimulated expression of these innate immune markers compared to monoassociation with individual strains ([@B22]). Finally, the presence or absence of sterilized diet significantly affected several of these host responses, underscoring an intimate and complex relationship between host, microbiota, and nutrient availability ([@B22]).

![Diverse effects of the microbiota on innate immune development and function in zebrafish. Colonization of germ-free zebrafish larvae with microbiota stimulates inflammatory gene expression (detected in specific tissues and whole larvae), neutrophil behavior and activity, neutrophil abundance in homeostasis, and neutrophil mobilization to injury. Boxes indicate different tissue-specific phenotypes that are known to be (black text) or are possibly (gray text) affected by microbiota.](fimmu-10-02100-g0001){#F1}

###### 

Conservation of microbiota-induced innate immune phenotypes in zebrafish and mice.

  **Cell/tissue type**   **Phenotype**                                      **Zebrafish**   **Mice**   **References**
  ---------------------- -------------------------------------------------- --------------- ---------- ----------------------------------
  Intestine              Increased pro-inflammatory mRNAs                   X               X          ([@B17], [@B67]--[@B69])
                         Increased alkaline phosphatase activity            X                          ([@B19], [@B33])
                         Increased nutrient absorption                      X               X          ([@B17], [@B67]--[@B72])
                         Exacerbation of intestinal injury                  X               X          ([@B20], [@B73]--[@B78])
                         Increased immune cell infiltration                 X               X          ([@B19], [@B28], [@B79])
                         Increased proliferation                            X               X          ([@B19], [@B64], [@B80])
  Myeloid Cells          Increased pro-inflammatory mRNAs                   X               X          ([@B28], [@B31], [@B81]--[@B83])
                         Increased bacterial killing activity                               X          ([@B11], [@B84]--[@B87])
                         Increased longevity                                                X          ([@B88], [@B89])
                         Increased systemic abundance                       X               X          ([@B28], [@B90])
                         Increased abundance in hematopoetic compartments                   X          ([@B6], [@B89]--[@B93])
                         Increased recruitment to wounds                    X               X          ([@B28], [@B31], [@B94])
                         Increased velocity and directional migration       X                          ([@B28])
  Whole animal           Protection against systemic microbial infection    X               X          ([@B30], [@B90], [@B92])

Motivated by previous monoassociation studies that identified individual bacterial taxa that differentially promote zebrafish lipid metabolism ([@B72]), a recent report assessed whole animal transcriptional responses to bacterial colonization of representative Firmicutes (*Exiguobacterium acetylicum*) and Bacteriodetes (*Chryseobacterium* sp.) commensal species. This study identified 65 genes that were uniformly differentially expressed in zebrafish either monoassociated with the commensal strains *E. acetylicum* or *Chryseobacterium* sp., or colonized by complex microbiota. These findings in whole zebrafish larvae, taken together with previous analyses of digestive tracts from monoassociated larvae, suggest that there may be shared host transcriptional responses evoked by colonization with diverse microbial taxa, although this remains to be determined with a more extensive panel of bacteria ([@B35]). Collectively, these findings demonstrate that specific bacterial strains in zebrafish are sufficient to elicit innate immune responses, and that complex microbial communities synergistically affect host innate immunity ([Table 1](#T1){ref-type="table"}).

A major challenge in understanding transcriptional regulatory networks that mediate host responses to microbiota is identification of the specific underlying transcription factors. Many innate immune genes are regulated by the highly conserved NF-κB transcription factor complex ([@B97]). Due to the optical transparency of zebrafish larvae, high resolution *in vivo* imaging of transcriptional reporter transgenes for key transcription factors provide unique opportunities to understand the spatiotemporal dynamics of microbiota-responsive signaling circuits. Our analysis of gnotobiotic zebrafish larvae harboring a transgenic NF-κB reporter, *Tg(NF*κ*B:EGFP)* ^*nc*1^, demonstrated that microbial signals induce NF-κB signaling in a variety of cell and tissue types in larval zebrafish, including absorptive and secretory cells within the intestine ([@B32]). Further analysis of intestinal NF-κB reporter dynamics demonstrated that this pathway is activated in part by bacterial flagellar motility. *P. aeruginosa* mutant strains lacking flagellar components or flagellar function failed to induce the NF-κB transgene in the intestine or increase expression of innate immune genes, *saa* and *mpx* in dissected digestive tracts ([@B32], [@B36]). Moreover, pharmacological and genetic inhibition of NF-κB/MyD88 signaling in zebrafish larvae abrogated the microbiota-dependent induction of innate immune genes including *complement factor b* (*cfb*) and *saa* ([@B32]). Microbiota-dependent stimulation of NF-κB in the intestine of zebrafish likely shapes host innate immunity. Genetic tools, including *myd88* mutants and PRR mutants, will provide key insights of the microbial signaling pathways that lead to innate immune responses mediated by commensal microbiota in zebrafish ([@B35], [@B98]).

MyD88 is an evolutionarily conserved TLR adaptor protein that initiates inflammatory signaling pathways following ligand recognition, ultimately leading to transcriptional induction of innate immune genes. Zebrafish genetically deficient in *myd88* are susceptible to acute infection by bacterial pathogens *Edwardsiella tarda* and *Salmonella typhimurium* ([@B98]). Findings from this work also demonstrated that expression levels of innate immune genes, including *il1b* and *mmp9*, as well as transcription factors, AP-1 and NF-κB, depend upon *myd88*. Moreover, gene expression analysis of whole larvae revealed that *myd88*, at least in part, mediates host sensing of MAMPs, Flagellin and LPS in zebrafish. Interestingly, *myd88* deficiency had no impact on the abundance of leukocyte populations in zebrafish larvae (mpx:GFP^+^ neutrophils and l-plastin^+^mpx:GFP^−^ macrophages) ([@B98]), which might suggest that the microbiota mediate leukocyte phenotypes via MyD88-independent mechanisms. However, this analysis was performed in 3 dpf larvae, coincident with the timepoint of canonical microbiota colonization. Indeed, a more recent report documented a decrease in the abundance of myeloperoxidase-positive intestine-associated neutrophils in *myd88* mutant larvae at 6 dpf ([@B99]). This underscores that the impact of microbiota on host innate immunity and the specific bacterial and host mechanisms mediating those interactions, may vary as a function of host developmental stage.

Intestinal Epithelial Cells (IECs) Regulate Systemic Innate Immunity in Response to Microbiota Colonization
-----------------------------------------------------------------------------------------------------------

Since the largest collection of microbes in the animal body typically reside in the intestine, the intestinal epithelium represents a large and critical component of the innate immune system. The intestine is constantly stimulated with environmental factors from both diet and the complex microbial community residing within the lumen. To maintain a symbiotic relationship with the gut microbiota, IECs must detect bacterial signatures and respond appropriately to modify host physiology. IECs are a critical node in the host circuitry which transduces information regarding the state of the microbiota to other distal tissues and cell types, including innate immune cells ([@B4], [@B95]). As such, IECs are important modulators of host innate immunity and dynamically respond to microbiota colonization in a number of ways detailed below.

One mechanism by which IECs coordinate responses to environment stimuli is through transcriptional programs. Gene expression is regulated through the action of transcription factors (TFs) that bind to *cis-*regulatory elements (CREs) in enhancer and promoter regions throughout the genome. Active enhancer regions are often situated in regions of accessible chromatin which, depleted of nucleosomes, allows for TF binding and transcriptional regulation. Active or poised enhancers can be identified in regions of accessible chromatin marked by specific nucleosome post-translational modifications including acetylation and methylation at conserved lysine residues (e.g., H3K27ac or H3K4me1) ([@B100]). Upon TF binding in an enhancer, transcription is either activated or suppressed, resulting in alterations in gene expression. Our genome-wide comparisons of gene expression and accessible chromatin in IECs from zebrafish, stickleback, mouse, and human recently revealed a conserved transcriptional network that has been conserved since their last common ancestor 420 million years ago ([@B17]). Notably, several TFs included in this conserved transcriptional network have known associations with the human Inflammatory Bowel Diseases (IBD) ([@B17]), which are known to be driven in part by aberrant interactions with the microbiota. Analysis of microbiota-responsive transcriptional regulatory pathways in zebrafish therefore have the potential to inform our understanding of host-microbiota interactions in humans and other mammals.

Microbiota colonization of the vertebrate intestine induces robust changes in IEC gene expression programs as observed in mice and zebrafish ([@B17], [@B67]--[@B69], [@B101]), yet does not significantly alter overall chromatin accessibility in mice ([@B62]). These data suggest that microbiota-dependent changes in intestinal gene expression does not rely on alterations to chromatin accessibility, and is instead likely driven by differential activity of TFs and enhancers. The identification of genomic mechanisms that mediate IEC responses to colonization is an active area of investigation. For example, our recent work in zebrafish and mice has identified Hepatocyte Nuclear Factor alpha (HNF4A) as an evolutionarily conserved TF that coordinates global changes in gene expression following microbial colonization ([@B67]). Mutation of *Hnf4a* in mouse IECs leads to intestinal inflammation ([@B102]) and genetic variants at human *HNF4A* have been linked to inflammatory bowel diseases ([@B102]--[@B106]). Analysis of enhancer activation in small intestinal IECs from gnotobiotic mice using chromatin-immunoprecipitation (ChIP) sequencing for acetylation marks associated with active enhancers (H3K27ac) revealed that microbiota colonization was correlated with activation of enhancers linked to microbially-induced genes, and deactivation of enhancers linked to microbially-suppressed genes ([@B67]). Interestingly, these microbiota-responsive enhancers in mice were enriched for binding motifs for several of the TFs previously identified in the conserved IEC transcriptional network shared between fishes and mammals such as HNF4, STAT, IRF, and ETS factor TFs ([@B17]). Collectively, these data indicate that the microbiota influence multiple conserved gene-regulatory mechanisms which ultimately affect host gene-expression programs and may contribute to inflammatory diseases.

Recognition of microbially-derived signals and metabolites through PRRs expressed in IECs contributes to the host immune response. Gene Ontology (GO) analysis of up-regulated genes in IECs (and dissected digestive tracts) following microbiota colonization include an over-representation of innate immune and defense response pathways in mice and zebrafish ([@B17], [@B62], [@B67]). More specifically, the intestinal microbiota promote expression of complement factors, anti-microbial peptides (AMPs), chemokines, and cytokines ([@B22], [@B28], [@B32], [@B62], [@B67], [@B68]). The coordinated transcriptional up-regulation of these secreted immunomodulatory factors following microbiota colonization shapes local and systemic innate immunity.

Several cytokines, chemokines, and other immunomodulatory proteins are constitutively expressed or induced in IECs following microbiota colonization ([@B62], [@B67], [@B68], [@B107]--[@B112]). As these host factors are secreted, they can have both autocrine and paracrine effects on adjacent cells or tissues. As many innate and adaptive immune cell types reside within the mammalian intestinal lamina propria (LP) as well as within/around the zebrafish intestine, IEC-derived cytokine factors shape the activation and function of the local immune cell milieu and promote proper immune development during homeostasis ([@B95]). In mice, IEC transcription of the inflammasome-dependent cytokines *Il1B* and *Il18* is induced following microbiota colonization ([@B67]). These cytokines promote innate immune cell recruitment and epithelial homeostasis ([@B113]--[@B115]). In zebrafish, microbiota-induced expression of the secreted apolipoprotein Saa in IECs promoted neutrophil recruitment to the gut while mediating systemic immune responses to bacterial infection and injury ([@B31]). Thus, IECs exhibit dynamic transcriptional responses to microbiota-derived signals in order to regulate local and systemic immunity.

Microbiota Influences Neutrophil Activity in Zebrafish
------------------------------------------------------

Commensal microbiota regulate innate immune cell development and function, which has important implications for health and disease. Neutrophils are the most abundant white blood cell in circulation in humans, and are typically the first innate immune cell type recruited to sites of injury or infection. Neutrophils are professional phagocytes that promote the clearance of microorganisms and cellular debris through a variety of mechanisms ([@B116]--[@B118]). Numerous reports from murine models highlight that neutrophil functions are mediated by microbiota colonization ([@B11]). In zebrafish, neutrophils have been identified and specific transgenic markers exist, including *Tg(lyz:EGFP)*^*nz*117^ and *TgBAC(mpx:EGFP)*^*i*114^ ([@B56], [@B119]) ([Table 2](#T2){ref-type="table"}). Similar to studies in mammalian models, microbiota colonization of larval zebrafish alters neutrophil behavior, intestinal infiltration, and transcriptional activation in homeostasis ([@B19], [@B28], [@B30], [@B31], [@B33], [@B35]). Our time-lapse imaging of neutrophils in GF and CV larvae demonstrated that neutrophils move with higher speed in tissues including the CHT, intestine, and the fin of colonized hosts. This neutrophil behavior is in part mediated through microbiota-induced secreted immunomodulatory protein Saa ([@B28], [@B31]). Moreover, qPCR analysis of pro-inflammatory mRNAs from sorted neutrophils illustrated that transcripts encoding cytokines (*tnfa*), ROS-producing enzymes (*mpx* and *ncf1*), and anti-microbial peptides (*pglyrp2* and *pglyrp5*) were more highly expressed in the presence of a microbiota ([@B28], [@B31]). These data suggest that the commensal microbiota elevate the inflammatory tone of neutrophils in zebrafish at homeostasis, which is associated with behavioral differences.

In addition to affecting multiple aspects of neutrophil biology systemically and in distal tissues, the microbiota also promote intestinal infiltration of neutrophils in zebrafish larvae. Colonized zebrafish larvae display augmented numbers of intestine-associated neutrophils relative to GF controls ([@B28], [@B30], [@B33], [@B35]). Studies using morpholino knockdown approaches revealed that *myd88* and *tnfr1* signaling promoted neutrophil recruitment to the gut in colonized zebrafish larvae ([@B33]). These data suggest that microbiota-derived MAMPS in the intestine signal through PRRs via MyD88 to potentiate neutrophil recruitment to the gut.

To assess the impact of specific bacterial species on intestinal neutrophil recruitment, gnotobiotic zebrafish larvae were monoassociated with a panel of zebrafish gut bacterial isolates and intestinal neutrophil numbers quantified ([@B29]). This work demonstrated that specific bacterial isolates, such as *Aeromonas* sp. and *Vibrio* sp., promoted higher levels of neutrophil abundance in the gut compared to strains like *Shewanella* sp. Furthermore, di-associations with pairwise combinations of these same strains revealed that the dominant species (i.e., the most abundant as determined by CFU plating) did not always positively correlate with intestinal neutrophil recruitment. Findings from this study revealed that *Shewanella* sp. secreted a factor that suppressed gut neutrophil recruitment. A subsequent study determined that *Aeromonas* sp. secreted an immunomodulatory protein "AimA" which prevented aberrant intestinal neutrophil recruitment ([@B34]). Together, these data demonstrate that specific microbial species can influence host innate immune cells independent of bacterial abundance within the gut, effects which may be mediated in part by secreted immunomodulatory factors or presentation of distinct surface antigens ([Table 1](#T1){ref-type="table"}).

Neutrophil abundance is elevated in colonized zebrafish larvae relative to GF, yet, it remains unclear if this is due to increased rates of production or longevity of neutrophil populations ([@B28]). In mice, the microbiota influence hematopoietic lineages at multiple stages of differentiation and commitment ([@B9]). It has been shown in murine models that bacterial products, such as peptidoglycan, signal to distal tissues including progenitor cells in the mammalian primary hematopoietic compartment, the bone marrow (BM) ([@B91]). Interestingly, the complexity of host associated microbiotas is positively correlated with the enhancement of steady state myelopoiesis ([@B91]). Studies in mice have further demonstrated that microbiota colonization is associated a with TLR4-MyD88 dependent increase in the abundance of not only BM HSCs, but also BM granulocyte and monocyte progenitors (GMPs), which positively correlates with increased numbers of BM and circulating neutrophils and monocytes ([@B90], [@B92], [@B93]). Exposure of GF mice to MAMPs is sufficient to promote differentiation of GMPs to myeloid cells, suggesting that microbial products or downstream signals expand the BM myeloid cell pool ([@B90]). Moreover, the microbiota promote circulating neutrophil longevity via a TLR2/4-MyD88 signaling axis ([@B89]). Collectively, these findings from murine models indicate that the abundance of BM and circulating myeloid cells are elevated through host detection of microbiota-derived molecular cues by PRRs. It is likely that the commensal microbiota influence myeloid cells at several stages of differentiation and development in zebrafish, but, in the absence of transgenic markers for GMPs or other precursors, this remains to be determined.

Microbiota Influence Innate Immune Responses to Peripheral Injury and Inflammation in Zebrafish
-----------------------------------------------------------------------------------------------

Following injury or infection, the concerted actions of innate immune cells (including macrophages, neutrophils, and dendritic cells) play critical roles in clearing pathogens, removing necrotic tissue, signaling to other cell-types, enhancing wound healing, and ultimately restoring homeostasis through a variety of mechanisms. Immediately following injury, local production of cytokines and inflammatory mediators initiates signaling cascades that recruit both circulating and tissue-resident immune cells to sites of injury ([@B118]). The ability to image leukocyte populations (such as neutrophils and macrophages) and interrogate their functions *in vivo* provides a novel platform to rigorously investigate the mechanisms underlying innate immune cell functions. In zebrafish, amputation of the caudal fin leads to a gradient of ROS, damage associated molecular patterns (DAMPs), and MAMPs which leads to leukocyte recruitment to the tail wound margin ([@B30], [@B120]--[@B123]). Studies in many vertebrate animal models have demonstrated that host-associated microbiota promotes the recruitment of innate immune cells to sites of trauma. Colonization by complex intestinal microbiota augmented neutrophil recruitment to a caudal fin amputation ([@B28], [@B30], [@B31]). Moreover, expression of the pro-inflammatory mRNAs *il1b* and *ccl-c25ab* were significantly elevated in wounded larvae colonized with a microbiota as compared to GF wounded larvae ([@B30]). This suggests that microbial signals are necessary for proper neutrophil mobilization in response to peripheral injury. Similarly, experiments in murine models demonstrated that neutrophil extravasation and recruitment following intraperitoneal injection of the chemoattractant zymosan is reduced in both GF mice and antibiotics treated mice as compared to specific pathogen free (SPF) in a *Myd88*-dependent manner ([@B94]). To our knowledge, the influence of the microbiota on macrophage recruitment to injury has yet to be described.

Perturbation of the intestinal microbiota is associated with intestinal inflammation and is thought to underlie the pathology of chronic intestinal diseases such as IBD. Indeed, many genetic mouse models of IBD, such as *Il10*^−/−^, require microbiota colonization to develop spontaneous colitis ([@B74]). Aspects of human IBD can also be modeled in zebrafish. For example, *uhrf1* mutant zebrafish larvae develop intestinal inflammation characterized by increased intestinal permeability, reduced epithelial thickness, and increased intestinal levels of the pro-inflammatory mRNA *tnfa* ([@B75]). Interestingly, GF *uhrf1* mutant larvae exhibit attenuated intestinal *tnfa* expression, demonstrating that the commensal microbiota exacerbate intestinal inflammation in this model. Similarly, pro-inflammatory effects of the microbiota have been documented in zebrafish using chemical models of intestinal injury including oxazolone ([@B20]), Trinitrobenzenesulfonic acid (TNBS) ([@B77]), dextran sodium sulfate (DSS) ([@B76]), soy saponin ([@B124]), and Glafenine ([@B73]) exposures. Zebrafish exposed to these chemical agents exhibited various manifestations of intestinal inflammation, including increased expression of pro-inflammatory mRNAs and myeloid cell infiltration to the gut, which were attenuated in animals reared GF or treated with antibiotics ([@B20], [@B73], [@B76], [@B77], [@B124]). Collectively, these studies demonstrate an evolutionarily conserved pro-inflammatory effect of the microbiota following genetic and chemical insult to the intestine.

The microbiota promote the development of the innate immune system, which facilitates enhanced pathogen elimination following infection. In zebrafish, GF larvae were more sensitive to viral infection by spring viremia of carp virus (SVCV), having higher mortality rates and decreased expression of anti-viral transcripts compared to conventionally raised zebrafish larvae ([@B30]). In mammals, the microbiota protects the host against systemic infection from bacterial pathogens (including *Escherichia coli, Klebsiella pneumoniae*, and *Listeria monocytogenes*) by accelerating production of circulating and BM neutrophils and monocytes ([@B90], [@B92]). In antibiotics-treated mice, reduced plasma concentrations of the granulopoietic cytokine G-CSF may explain the failed granulocytic response following bacterial infection ([@B92]). Products derived from the microbiota can also mediate the killing activity of host BM myeloid cells. Microbial products, such as peptidoglycan, have been detected in the serum of colonized mice, suggesting that microbial factors can traverse the intestinal epithelium and enter circulation ([@B86]). Detection of microbiota-derived peptidoglycan by NOD1 enhanced BM neutrophil phagocytosis of *Streptococcus pneumoniae* and *Staphylococcus aureus* ([@B86]). Technical hurdles in zebrafish, including their relatively small size and the current lack of transgenic reporters labeling myeloid progenitor cell populations, has thus far prevented analysis of microbiota-dependent impacts on the differentiation, abundance, and activities of myeloid cell populations within hematopoietic compartments.

Host Strategies to Control Resident Microbiota and Innate Immune Tolerance in Zebrafish
---------------------------------------------------------------------------------------

Collectively, the intestinal microbiota promotes increased numbers of myeloid cells (in circulation and the BM of mice; in the intestine and whole animal in zebrafish) as well as their bactericidal activity ([@B11]). However, the host must balance this response to temper excessive innate immune system activation. While we observe elevated pro-inflammatory signaling following microbiota colonization, there is also a concomitant activation of anti-inflammatory pathways. It has recently become appreciated that there are host mechanisms to limit aberrant activation of the innate immune system by the microbiota. As detailed below, work in zebrafish has provided novel insights into mechanisms of immune tolerance to the microbiota. By integrating powerful genetic manipulations with facile gnotobiotics in zebrafish, we recently demonstrated that the host apolipoprotein Serum amyloid a (Saa) was induced following microbiota colonization and suppressed neutrophil bactericidal activity and expression of pro-inflammatory mRNAs, thus restricting aberrant activation ([@B31]).

Colonization of the intestine by commensal bacteria is accompanied by a concomitant increase in the lumenal concentration of LPS within the intestine. To counteract the pro-inflammatory and potentially toxic effects of increased LPS signaling, intestinal alkaline phosphatase activity increases to detoxify LPS ([@B19]). In zebrafish larvae, expression of *intestinal alkaline phosphatase* (*iap*) is induced in IECs following bacterial colonization in a Myd88 dependent manner, and restricted excessive neutrophil recruitment to the gut following microbial colonization ([@B33]). IAP was subsequently shown to also play important roles in gut mucosal homeostasis in mice ([@B125]), illustrating the ability of the zebrafish to uncover novel and conserved mechanisms underlying host-microbiota interaction.

Further work has shown that the enteric nervous system (ENS) promotes intestinal homeostasis by controlling the composition of the microbiota. Zebrafish larvae with a mutation in *sox10*, a gene associated with Hischsprung\'s disease in humans, exhibited impaired intestinal motility and intestinal bacterial overgrowth by pro-inflammatory taxa including *Vibrio* spp. ([@B126]). This leads to increased intestinal inflammation characterized by elevated intestinal neutrophil infiltration and proinflammatory gene expression. The zebrafish model affords exciting opportunities to study intestinal motility and spatial patterns of microbiota colonization using high resolution *in vivo* imaging coupled with genetic manipulation of ENS function ([@B127], [@B128]).

Future Directions and Perspectives {#s2}
==================================

Comparison between innate immune processes in gnotobiotic zebrafish and mice have revealed extensive conservation between these host species ([Table 3](#T3){ref-type="table"}). This suggests that these host responses to the microbiota are ancient and were likely present in the last common ancestor over 420 million years ago ([@B129]). The emergence and evolutionary maintenance of these host responses to microorganisms illustrate that these are deeply important aspects of vertebrate biology, with zebrafish affording a unique experimental platform to study the dynamic host-microbe interface. Moving forward, the zebrafish is a model well-poised to provide insights of host-microbe interactions at several body sites, not just the intestine.

Studies in zebrafish have advanced our understanding of the effects of commensal microbiota colonization on host innate immune function. However, caution should be taken when making comparisons between published studies due to differences in developmental timepoints, host genetic background, transgenes used to monitor different cellular populations, as well as environmental variables such as nutrition, time of day, rearing temperature and media composition, all of which may impact microbiota-dependent and -independent host phenotypes. Moreover, while the small size of the larval zebrafish makes them amenable to *in vivo* imaging, this precludes longitudinal fecal and blood sampling, and restricts terminal tissue harvest to either whole animal or dissected digestive tracts (which can easily be contaminated by liver and pancreas in addition to the intestine due to the difficulty of precisely separating tissues manually). As a result many host responses have been evaluated from whole animal preparations, making it difficult to deconvolve the extent of variation in cell-type specific responses across distinct tissues and anatomical compartments. Moreover, as many innate immune lineages are lowly abundant (e.g., neutrophils typically represent \~1% of the total cell population in conventionally reared larvae at 6 dpf), bona fide leukocyte phenotypes may be lost due to signal-to-noise dilution in whole animal assessments. Fluorescence activated cell sorting (FACS) is one technological approach to overcome some of these limitations ([@B31], [@B73]). Additionally, the continued development of microdissection techniques using microneedles to sample small blood volumes or tissues will permit molecular analyse of distinct cellular populations from zebrafish larvae ([@B130]). These approaches, in combination with the advent of low-input molecular techniques (from PCR to single-cell sequencing), present exciting opportunities to parse the effects of the microbiota on rare and/or specific cell populations.

Molecular tools, such as antibodies, are underdeveloped in the zebrafish model, significantly limiting immunofluorescence and flow cytometry assays. Therefore, transgenesis has emerged as a powerful system for monitoring the spatiotemporal behavior and activation of specific cell populations *in vivo*. Numerous transgenic lines have been created to visualize and study specific immune cell types in zebrafish ([Table 2](#T2){ref-type="table"}). Due to the lack of existing reagents that specifically label some myeloid cell types, there are large knowledge gaps in understanding microbiota impacts on zebrafish innate immunity focusing on key immune cell types including mast cells and dendritic cells. Macrophage-specific promoter sequences (from genes including *fms, mpeg1, mfap4*, and *irg1*) have been used to drive a variety of transgenic reporters ([@B57], [@B58], [@B131], [@B132]). Though the impact of microbiota on zebrafish macrophage biology lags far behind that of neutrophils, there are reports of a reduction of *mpeg1*^+^ macrophages in the distal intestine of colonized 5 dpf larvae ([@B35]) ([Table 2](#T2){ref-type="table"}).

Despite the utility of transgenes in zebrafish, it is important to consider that the use of small promoter elements to engineer transgenic zebrafish may also led to pleiotropic labeling and varied lineage specificity of existing reagents. Moreover, these reagents are inherently transcriptional reporters which might exhibit dynamic behaviors following microbial colonization, injury, or infection ([@B28], [@B133]) ([Table 2](#T2){ref-type="table"}). In the future, the application of targeted knock-in methods to insert fluorescent proteins or tags directly into a genomic locus of interest may more faithfully recapitulate endogenous expression patterns of these genes.

Previous reports have focused on microbiota-dependent effects on innate immunity from zebrafish between 3 and 8 dpf. Current dogma supports a model whereby zebrafish larvae are initially exposed to environmental microorganisms at 3 dpf after hatching from their chorions. Thus, in designing experiments it may be prudent to include assays representative of later stages of larval development to allow for the establishment of microbiotas within the host ([@B24]). However, it is formally possible that MAMPs may be able to penetrate the chorion at earlier stages of zebrafish development (prior to hatching at 3 dpf). A number of recent studies in zebrafish have shown that inflammatory signaling pathways are important in promoting the niche for the development of HSCs ([@B134], [@B135]). This raises the possibility that early life exposures to microbial cues may shape host innate immunity, including the development of the hematopoietic compartment. While recent studies have begun to explore the effects of microbial exposure at other timepoints (as early as 1 dpf) ([@B63]), associated immunological phenotypes remain unexplored. Conversely, analysis of microbiota-dependent immune phenotypes during juvenile and adult stages of the zebrafish lifecycle remain almost completely unexplored. Methods to rear zebrafish GF past 2 weeks of life remain technically challenging but would provide valuable insights into microbial influence on zebrafish adaptive immune development as well as metamorphosis ([@B27]).

Variation in experimental results using the zebrafish model may also be attributed to underlying differences in microbiota composition across zebrafish facilities ([@B21]). Colonization of gnotobiotic zebrafish with defined consortia of bacteria could provide a standardized community that may offer a deeper understanding of taxa-specific impacts on vertebrate innate immune development and could improve experimental consistency and reproducibility.

Zebrafish offer unprecedented potential for experimental dissection of the bacterial products and signals that contribute to systemic innate immunity in the intact physiologic context of a living vertebrate. Using established techniques, it is now feasible to introduce bacterial mutant libraries or panels of bacterial strains into gnotobiotic zebrafish larvae to begin to disentangle the mechanisms by which the microbiota influence host innate immunity in medium-throughput screens. Zebrafish larvae mono- or poly-associated with defined bacterial taxa can be evaluated for effects on leukocyte responses during homeostasis or following challenge (e.g., recruitment to peripheral injury) by interrogating leukocyte abundance or activation (e.g., expression of inflammatory mRNAs). Further, coupling the genetic and pharmacological tractability of zebrafish with gnotobiotic manipulations allows for the identification and manipulation of genetic and molecular determinants of host-microbiota interactions *in vivo*. In combination, application of these medium-scale immersion strategies to gnotobiotic zebrafish will provide insights into host-microbiota-chemical interactions with relevance to toxins and pharmaceutical toxicity and metabolism ([@B136]). The emergence of organoid culture technology platforms derived from mammalian models presents exciting opportunities to monitor intestinal physiologies in a more scalable system, however these platforms do not provide the full anatomic and physiological complexity of the intact vertebrate digestive system afforded in the zebrafish. The optical transparency and numerous transgenic reporter lines available in zebrafish can be coupled with medium-scale imaging approaches to monitor host responses, unearthing novel interactions in the context of a whole living organism.
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